The economic burden of TNFα inhibitors and other biologic treatments in Norway
Jan Norum1, Wenche Koldingsnes2, Torfinn Aanes3, Margaret Aarag Antonsen4, Jon Florholmen5, Masahide Kondo61Northern Norway Regional Health Authority, Bodø, Norway; 2Department of Rheumatology, University Hospital of North Norway, Tromsø, Norway; 3Drug Procurement Coope...
Main Authors: | Jan Norum, Wenche Koldingsnes, Torfinn Aanes, et al |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2011-03-01
|
Series: | ClinicoEconomics and Outcomes Research |
Online Access: | http://www.dovepress.com/the-economic-burden-of-tnfalpha-inhibitors-and-other-biologic-treatmen-a6779 |
Similar Items
-
Probing the mechanical properties of TNF-α stimulated endothelial cell with atomic force microscopy
by: Sei-Young Lee, et al.
Published: (2011-01-01) -
Spinal delivery of p38: TNF-alpha inhibitors.
by: Edward Tobinick
Published: (2006-11-01) -
Epidemiology of ANCA associated vasculitis
by: Wenche Koldingsnes, et al.
Published: (2008-01-01) -
The use of anti-TNFα medications for rheumatologic disease in pregnancy
by: Megan EB Clowse
Published: (2010-06-01) -
Calcineurin inhibitors in steroid and anti‐TNF‐alpha refractory immune checkpoint inhibitor colitis
by: Eva Zhang, et al.
Published: (2021-05-01)